로딩 중…
지수 로딩 중…
Kardigan Inc. Common Stock
KARD· NASDAQ· Health Care
$16.64-0.30%
2026-09-18
Financials
Valuation Metrics
Kardigan Inc. Common Stock's Market Cap is $1.49B. Ranked #2220 of 3,119 in US market (top 71%), #881 of 1,463 on NASDAQ (top 60%) by Market Cap.
Investment Metrics(as of 2026-09-19)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.49B | US#2,220/3,119 |
| Revenue | $0.00 | US#2,889/3,119 |
| Net Income | $-192M | US—/3,119 |
| Total Assets | $391M | US#2,853/3,119 |
| Net Assets | $-250M | US#2,998/3,119 |
| Employees | 241 | US#2,462/3,119 |
| Value | ||
| FCF Yield | -10.61% | US—/3,119 |
| Profitability | ||
| ROA | -49.10% | US#2,986/3,119 |
| Financial Health | ||
| Total Debt | $14M | US#2,806/3,119 |
| FCF | $-158M | US#2,730/3,119 |
| Cash | $109M | US#2,184/3,119 |
| Current Ratio | 9.20x | US#283/3,119 |
| Performance | ||
| 1M Return | -24.40% | US#3,021/3,119 |
| From 52W High | -38.37% | US#2,397/3,119 |
| 1Y MDD | -35.75% | US#1,787/3,119 |
| Trading | ||
| Volume | 4,648,916 shares | US#502/3,119 |
| Trading Value | $77M | US#1,172/3,119 |
| Per Share | ||
| EPS | $-2.15 | US—/3,119 |
| BPS | $-2.80 | US—/3,119 |
Company Info
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.